Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, S…
Baxter Healthcare Corporation · CGMP Deviations
- Status
- Ongoing
- City
- Deerfield
- State
- IL
- Country
- United States
- Classification
- Class II
- Product type
- Drugs
- Event ID
- 99500
- Recalling firm
- Baxter Healthcare Corporation
- Address 1
- 1 Baxter Pkwy
- Address 2
- N/A
- Postal code
- 60015-4625
- Voluntary mandated
- Voluntary: Firm initiated
- Initial firm notification
- Letter
- Distribution pattern
- US Nationwide; Puerto Rico; and Chile.
- Recall number
- D-0821-2026
- Product quantity
- N/A
- Reason for recall
- CGMP Deviations
- Recall initiation date
- 20260806
- Center classification date
- 20260828
- Report date
- 20260909
- Code info
- Lot # NC193856, Exp Date: 04/18/2028.
- Product description
Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.
- Harmonized identifiers (openFDA)
- Application number
- NDA213645
- Brand name
- DAPTOMYCIN IN SODIUM CHLORIDE
- Generic name
- DAPTOMYCIN IN SODIUM CHLORIDE
- Manufacturer name
- Baxter Healthcare Corporation
- Product NDC
- 0338-0712, 0338-0714, 0338-0716, 0338-0718
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- DAPTOMYCIN
- RxCUI
- 2632127, 2632130, 2632132, 2632133
- SPL ID
- 42d6b08e-92f7-433d-b695-7037493ec2e8
- SPL set ID
- 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef
- Package NDC
- 0338-0712-24, 0338-0714-24, 0338-0716-12, 0338-0718-12
- Is original packager
- true
- Nui
- N0000175509, M0519359
- Pharm class epc
- Lipopeptide Antibacterial [EPC]
- Pharm class cs
- Lipopeptides [CS]
- UNII
- NWQ5N31VKK
